Mounjaro
Entity.
- Evidence
- 56 documents · 34 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 3 Sept 2026, last seen 8 Oct 2026
- Measured
- 27% of mentions say something specific about it; the rest only name it
- As of
- 8 Oct 2026
Where this comes from
- Seoul Economic Daily · 2026-10-08 · Korea's First Homegrown Obesity Drug Clears Approval, Launch Set for October (opens the source in a new tab)
- 24/7 Wall St. · 2026-10-07 · Lilly’s Worst Entry Points Were Its Most Hyped Approvals Mounjaro and Zepbound (opens the source in a new tab)
- Medical Xpress · 2026-10-07 · WHO says no obesity drugs, surgery for under-10s (opens the source in a new tab)
- TIME · 2026-10-07 · Compounding Pharmacies for Weight-Loss Drugs Are Booming. Should You Trust Them? (opens the source in a new tab)
- MIT Technology Review · 2026-10-06 · Weight-loss drugs show signs of slowing biological aging, say drugmakers (opens the source in a new tab)
- Seoul Economic Daily · 2026-10-06 · Samsung Biologics Positions Itself as Key Partner for Blockbuster Drugs (opens the source in a new tab)
- Seoul Economic Daily · 2026-10-06 · Korea's Adult Obesity Rate Hits Record 35.4% (opens the source in a new tab)
- Seoul Economic Daily · 2026-10-06 · Korea Catches 949 Illegal Online Listings for Weight-Loss Drugs (opens the source in a new tab)
- Medical Daily · 2026-09-29 · FDA Flagged GLP-1 Vision Loss Signal in 2025, but U.S. Ozempic and Mounjaro Labels Still Lack NAION Warning (opens the source in a new tab)
- Latest Science News -- ScienceDaily · 2026-09-27 · Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat (opens the source in a new tab)
- Korea Times · 2026-09-22 · Wegovy, Mounjaro help Korean doctor navigate lifelong struggle with obesity (opens the source in a new tab)